| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.093 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |